
For several urologists, the concept behind reform was strong, but the logistics of implementing it are daunting.

For several urologists, the concept behind reform was strong, but the logistics of implementing it are daunting.

With a new, Republican-controlled House of Representatives and more GOP votes in the Senate, what are the chances of finally achieving a permanent fix of the Medicare fee schedule that has plagued urologists and every other physician who treats Medicare patients for years?

The experience of one center with vaginal mesh kits for prolapse repair shows that morbidity can be acceptable and patient satisfaction rates high-in the hands of very experienced surgeons.

The newest urology products and services from Ethicon, Inc., Calypso Medical Technologies, Inc., the American College of Surgeons Health Policy Research Institute, Siemens Healthcare, the Turek Clinic, American Medical Systems, the Employers Action Coalition on Healthcare, and Massachusetts General Hospital.

Men with mild to moderate stress incontinence following radical prostatectomy may find relief with a newer-generation male sling.

Urologists have strong opinions about politics and health care reform. About four out of five urologists are extremely or very concerned about declining reimbursement, increasing government regulations, and health care reform regulations.

A structured product is a contract that promises to pay a future amount based on the performance of an underlying asset, such as a stock, market index, or commodity. The payoff is usually linked to a preset formula.

Leonard G. Gomella, MD, co-investigator of the REDUCE trial, discusses what has been learned from three prostate cancer prevention trials and the future of prostate cancer chemoprevention.

Nanoparticle technology shows promise for improving the tissue-ablating efficiency of transurethral microwave therapy for treating BPH.

Urologists choose flexible options when obtaining CME credit.

Transobturator and retropubic mid-urethral sling procedures appear to have equivalent efficacy but show different complications when used for the treatment of female stress urinary incontinence.

This article will help you understand the dynamics of selling your practice and explain how to accomplish this once-in-a-lifetime transaction.

A pilot study evaluating spinal nerve re-routing to restore bladder and bowel function in children with spina bifida has generated some promising results that are a basis for undertaking a larger and more rigorous multicenter trial.

I never joined the transrectal biopsy herd. I stuck with the perineal biopsy, which has been proven in a head-to-head trial to have a better yield of cancer.

Intraspinal nerve rerouting to establish a reflex pathway from skin to spinal cord to bladder is a safe procedure in spinal cord injured patients, but does not allow patients to initiate voluntary micturition.

The net effect of these changes for urology is a bump in the total values for many of the services that are provided.

Patient satisfaction with incontinence surgery remains high at a follow-up of up to 7 years despite declining continence rates over time, according to the authors of a large, multicenter study.

In men treated with dutasteride (Avodart) for prostate cancer, the frequency of acute urinary retention, prostate surgery, and BPH symptoms decreases irrespective of prostate volume or symptom severity.


The Centers for Medicare & Medicaid Services has published the category I CPT code for posterior tibial nerve stimulation (PTNS) in the November 2010 Federal Register, according to Uroplasty Inc., Minneapolis.

Nearly 87% of patients who underwent robot-assisted radical prostatectomy had no disease recurrence after 5 years, according to a recent multicenter study.

The American Board of Urology has adopted several new policies in areas such as expert witnesses in medical liability cases and expired/revoked certificates.

A monoclonal antibody targeting a well-known cell-surface protein inhibits the growth and spread of castration-resistant prostate cancer, say researchers from UCLA.

When Medicare policy changes led to reductions in reimbursement for androgen deprivation therapy in prostate cancer patients, a sharp decline in its use was seen among patients not likely to benefit from the treatment, reported researchers from the University of Michigan, Ann Arbor.

Urologists and other physicians who treat Medicare patients will see a total reimbursement reduction of 24.9% in 2011 under the Medicare physician fee schedule, according to the recently released Centers for Medicare & Medicaid Services? final rule for 2011.

David B. Samadi, MD, has been named vice chair of the department of urology at The Mount Sinai Medical Center, New York.

After years of unsuccessful efforts by numerous investigators, researchers have found a way to propagate primary human Sertoli cells in the laboratory?the first step, say the researchers, to developing an artificial human testicle for reproductive research.

A majority of men dying from prostate cancer wait too long to enroll in hospice care and cannot take full advantage of the palliative care that could make their deaths easier, researchers from UCLA's Jonsson Comprehensive Cancer Center recently reported.

Men with prostate cancer who take anticoagulants like aspirin, in addition to undergoing radiation therapy or surgery, may be able to cut their risk of dying of the disease by more than half, recent research indicates.

The FDA has asked drug manufacturers to add new warnings to labeling of gonadotropin-releasing hormone agonists to alert patients and health care professionals to the potential risk of heart disease and diabetes in men treated with these medications for prostate cancer.